---
title: "CHENGDA PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 16.7733 million yuan, a decrease of 58.47%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262883081.md"
description: "CHENGDA PHARMA released its third-quarter report for 2025, with operating revenue of 285 million yuan in the first three quarters, a year-on-year increase of 16.95%. The net profit attributable to the parent company was 16.7733 million yuan, a year-on-year decrease of 58.47%; the net profit after deducting non-recurring gains and losses was 3.9025 million yuan, a year-on-year decrease of 72.96%. The basic earnings per share were 0.1107 yuan"
datetime: "2025-10-27T11:32:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262883081.md)
  - [en](https://longbridge.com/en/news/262883081.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262883081.md)
generator: "portal-rs"
---

# CHENGDA PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 16.7733 million yuan, a decrease of 58.47%

According to the Zhitong Finance APP, CHENGDA PHARMA (301201.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 285 million yuan, a year-on-year increase of 16.95%. The net profit attributable to shareholders of the listed company was 16.7733 million yuan, a year-on-year decrease of 58.47%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.9025 million yuan, a year-on-year decrease of 72.96%. The basic earnings per share were 0.1107 yuan

### Related Stocks

- [301201.CN](https://longbridge.com/en/quote/301201.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian](https://longbridge.com/en/news/296607308.md)
- [Flash Sports & Media faces Nasdaq trading suspension over listing rule breach](https://longbridge.com/en/news/296655108.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**